Prakt. lékáren. 2015; 11(4): 123-125
Modern trends in the ovarian stimulation
- REPROMEDA s. r. o., Brno
The ovulation stimulation is essential procedure for most methods of reproductive medicine. Modern trends in stimulation lie in the
individualized stimulation, the safety enhancement, the application facilitation including the depot injections use, and enabling the
treatment of the patients, requiring special stimulation procedures, such as the polycystic ovarian syndrome and tumour risk.
safety.
Keywords: reproductive medicine, ovarian stimulation, gonadotropins, gonadoliberin analogs, individualized stimulation, stimulation
Published: September 15, 2015 Show citation
References
- Trávník P, Čech S. Základy obecné a speciální embryologie pro klinické embryology. YBUX s. r. o. 2011; 143 s. ISBN: 978-80-904697-0-9.
- Spritzer PM, Motta AB, Sir-Petermann T, Diamanti-Kandarakis E. Novel strategies in the management of polycystic ovary syndrome. Minerva Endocrinol. 2015 Mar 17. [Epub ahead of print].
- Nelson MS, Klein BM, Joan-Carles Arce J-C. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertil. Steril. 2015; 103(4): 923-930.
Go to original source... 
Go to PubMed... - Zech NH, Zech M, Baldauf S, Comploj G, Murtinger M, Spitzer D, Hradecký L, Ajayi R, Schuff M, Zech H. Ovarian stimulation in ART - Unwinding pressing issues. Minerva Ginecol. 2015; 67(2): 127-47. Epub 2015 Feb 10. Go to PubMed...
- Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014 Oct 31;10:CD008046. doi: 10.1002/14651858.CD008046.pub4. Go to original source... Go to PubMed...
- Albuquerque LE, Tso LO, Saconato H, Albuquerque MC, Macedo CR. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles. Cochrane Database Syst Rev. 2013; 1:CD002808. doi: 10.1002/14651858.CD002808.pub3. Go to original source... Go to PubMed...
- Johnson NP. Metformin use in women with polycystic ovary syndrome. Ann Transl Med. 2014; 2(6): 56. doi: 10.3978/j.issn.2305-5839.2014.04.15. Go to PubMed...
- Bj?rnholt SM, Kjaer SK, Nielsen TS, Jensen A. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study. Hum Reprod. 2015; 30(1): 222-231. doi: 10.1093/humrep/deu297. Epub 2014 Nov 5. Go to original source... Go to PubMed...
- Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013; 8: CD008215. doi: 10.1002/14651858.CD008215.pub2. Go to original source... Go to PubMed...
- Spaan M, van den Belt-Dusebout AW, Schaapveld M, Mooij TM, Burger CW, vanLeeuwen FE. Melanoma risk after ovarian stimulation for in vitro fertilization. Hum Reprod. 2015 Mar 4. pii: dev023. [Epub ahead of print]. Go to original source... Go to PubMed...
- Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Ferti Steril (2013) 99: 1476-84. doi: 10.1016/j.fertnstert.2013.03.029. Go to original source... Go to PubMed...
- Rodriguez-Wallberg KA, Oktay K. Fertility preservation in women with breast cancer. Clin Obstet Gynecol 2010; 53: 753-762. doi: 10.1097/GRF.0b013e3181f96e00. Go to original source... Go to PubMed...
- Coyne K, Purdy M, O'Leary K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and considerations in optimizing ovarian stimulation protocols in oncofertility patients. Front. Public Health, 05 December 2014 |doi: 10.3389/fpubh.2014.00246. Go to original source... Go to PubMed...